Advisory Committees

Translational Committee Asthma Prevention Consortium

The Translational Committee for the Asthma Prevention Consortium was formed with the aim to steer the scientific strategy and expedite the translation of scientific discovery into meaningful health outcomes. Members of the Committee:

  • Jeffrey Drazen, MD
    Editor-in-Chief of the New England Journal of Medicine
    Distinguished Parker B. Francis Professor of Medicine, Harvard Medical School
  • Paul Peter Tak, PhD, MD
    CEO Kintai Therapeutics
    Professor of Medicine, University of Amsterdam
  • Anne Leendertse, PhD
    Clinical Pharmacist 
    Patient representative
  • René Raggers, PhD
    Senior European and Dutch Patent Attorney
  • Hans Bisgaard, MD, DMSc
    Professor of Pediatrics
    Copenhagen Prospective Studies on Asthma in Childhood (COPSAC)
Translational Committee

FLTR Paul Peter Tak, Iman Schultz (Longfonds), Jeffrey Drazen, René Raggers, Anne Leendertse, Hans Bisgaard

Patient Advisory Committee Asthma Prevention Consortium

To emphasize the Lung Foundation Netherlands’ commitment to its patient interest agenda, a Patient Advisory Committee (PAC) is actively involved in the Asthma Prevention Consortium. The participation of patient representatives affords the consortium direct insight into the issues and challenges faced by lung patients, esp. asthma. The PAC is responsible for identifying and prioritizing topics to be addressed by the consortium from the patient perspective. Their involvement improves outcomes for lung patients and ensures successful implementation of future products. Members of the Committee (as of April 2019):

  • Bianca Bosman, the Netherlands
  • Jesca Groenendijk, the Netherlands
  • Anne Leendertse, the Netherlands
  • Martine Puhl, the Netherlands
  • Amanda Roberts, United Kingdom

FLTR Anne Leendertse, Martine Puhl, Jesca Groenendijk and Amanda Roberts. 

Advisory Board for Lung Regeneration

An Advisory Board for the Lung Regeneration Consortium is being set up with the aim to advice the consortium ànd the Board of the Lung Foundation about scientific strategies, expedite the translation of scientific discoveries and identify topic to be addressed by the consortium for the patients perspective.